dc.contributor.author |
Arıbaş, Emel Türk |
|
dc.contributor.author |
Bitirgen, Mehmet |
|
dc.contributor.author |
Günaydın, Murat |
|
dc.contributor.author |
Polat, Hakkı |
|
dc.date.accessioned |
2015-11-27T12:26:51Z |
|
dc.date.available |
2015-11-27T12:26:51Z |
|
dc.date.issued |
1996 |
|
dc.identifier.citation |
Arıbaş, E. Türk., Bitirgen, M., Günaydın, M., Polat, H.,(1996). Lösemi ve lenfomalı hastalarda herpes simpleks virüs tip 1 (hsv-1) antikorlarının araştırılması.Turgut Özal Tıp Merkezi Dergisi, 3 (3).173-176 ss. |
tr_TR |
dc.identifier.uri |
http://www.totmdergisi.org/articles/1996/volume3/issue3/1996_3_3_7.pdf |
|
dc.identifier.uri |
http://hdl.handle.net/11616/2743 |
|
dc.description |
[Journal of Turgut Ozal Medical Center 1996;3(3):173-176] |
tr_TR |
dc.description.abstract |
Herpes simplex virus tip 1 (HSV-1) antikorları, 85 lösemi ve lenfomalı hasta ve 40 sağlıklı kişide ELİSA yöntemi ile araştırılmıştır. Hasta grubunda HSV-1 IgM ve IgG pozitifliği sırasıyla % 9.41 ve % 92.95, kontrol grubunda da % 0.0 ve % 90 bulunmuştur. İstatistiksel olarak kontrol grubuna göre lösemi ve lenfomalı hastalarda HSV-1 IgM pozitifliği anlamlı olarak yüksektir. HSV-1 IgG antikorları yönünden ise hasta ve kontrol grubu arasında anlamlı fark bulunamadı. HSV-1 IgM ve IgG bakımından lösemi ve lenfomalı hastalar artasında da fark bulunamadı. Ayrıca antineoplastik tedavi alan ve almayan hastalar arasında da fark yoktu. |
tr_TR |
dc.description.abstract |
Herpes simplex virus type 1 (HSV-1) antibodies were investigated in 85 patients with leukemia and lymphoma and 40 healthy controls by ELISA. In patients HSV-1 IgM and IgG antibodies were found 9.41 % and 92.95 % respectively. In controls the same antibodies were found as 0.0 % and 90 %. Stastically, HSV-1 IgM seropositivity in patients with leukemia and lymphoma was higher than the control group. But there was not a significant difference between patients and control group for HSV-1 IgG. There was not a difference between the patients with leukemia and the patients with lymphoma for HSV-1 IgM and IgG. No significant difference was present between the patients treated with antineoplastic chemotherapy and the patients not treated. |
tr_TR |
dc.language.iso |
tur |
tr_TR |
dc.publisher |
İnönü Üniversitesi Tıp Fakültesi Dergisi |
tr_TR |
dc.rights |
info:eu-repo/semantics/openAccess |
tr_TR |
dc.subject |
Herpes simplex virus antibodies |
tr_TR |
dc.subject |
Leukemia |
tr_TR |
dc.subject |
Lymphoma |
tr_TR |
dc.subject |
Herpes simplex virus antibodies |
tr_TR |
dc.subject |
Leukemia |
tr_TR |
dc.title |
Lösemi ve lenfomalı hastalarda herpes simpleks virüs tip 1 (hsv-1) antikorlarının araştırılması |
tr_TR |
dc.title.alternative |
The Investigation of Herpes simpleks virus type-1 (HSV-1) antibodies in patients with leukemia and lymphoma |
tr_TR |
dc.type |
article |
tr_TR |
dc.relation.journal |
Turgut Özal Tıp Merkezi Dergisi |
tr_TR |
dc.contributor.department |
İnönü Üniversitesi |
tr_TR |
dc.contributor.authorID |
TR13066 |
tr_TR |
dc.contributor.authorID |
TR13066 |
tr_TR |
dc.identifier.volume |
3 |
tr_TR |
dc.identifier.issue |
3 |
tr_TR |
dc.identifier.startpage |
173 |
tr_TR |
dc.identifier.endpage |
176 |
tr_TR |